Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
14.30
+0.24 (1.71%)
May 29, 2026, 4:00 PM EDT - Market closed
Apollomics Employees
Apollomics had 14 employees as of December 31, 2025. The number of employees increased by 1 or 7.69% compared to the previous year.
Employees
14
Change (1Y)
1
Growth (1Y)
7.69%
Revenue / Employee
$631,571
Profits / Employee
-$781,357
Market Cap
31.75M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 14 | 1 | 7.69% |
| Dec 31, 2024 | 13 | -32 | -71.11% |
| Dec 31, 2023 | 45 | 2 | 4.65% |
| Dec 31, 2022 | 43 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Senti Biosciences Holdings | 39 |
| Lisata Therapeutics | 21 |
| Tevogen Bio Holdings | 18 |
| NeuroSense Therapeutics | 17 |
| Barinthus Biotherapeutics | 14 |
| Tvardi Therapeutics | 12 |
| Skye Bioscience | 12 |
APLM News
- 14 days ago - Apollomics Registration statement: Registration filing - Filings
- 4 weeks ago - Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress - GlobeNewsWire
- 4 weeks ago - Apollomics Annual report: Q4 2025 - Filings
- 4 weeks ago - Apollomics Earnings release: Q4 2025 - Filings
- 2 months ago - Apollomics Inc. Announces $2.0 Million Bridge Financing - GlobeNewsWire
- 2 months ago - Apollomics files to sell 279,775 Class A Ordinary shares for holders - TheFly
- 2 months ago - Apollomics Registration statement: Registration Filing - Filings
- 5 months ago - Apollomics Inc trading resumes - TheFly